The Future of Cell and Gene Therapy: Experts’ Perspectives

In this eBook, we explore the future of cell and gene therapy from the perspective of eight experts in the field: Adrian Bot from Capstan Therapeutics, Santoshkumar Khatwani from Sangamo Therapeutics, Michael Leek from TCB, Chris Lorenz from Astellas Gene Therapies, Snehal Naik from Spark, Barbra Sasu from Allogene, David Sourdive from Cellectis and Mark White from Bio-Rad. 

Chapters will cover:

• Five biggest trends of AAV-based gene therapies
• Regulatory expectations & guidelines around AAV gene therapy
• Five biggest trends of gene-modified cell therapy
• Harnessing analytical technologies to modify your AAV development workflow
• Tips for meeting regulatory guidelines for AAV development

Please enter your email to access content Read now